BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30535913)

  • 41. Multiplex amplification and fluorimetric detection of short tandem repeats for mixed chimerism after bone marrow transplant.
    Madeo D; Cappellari A; Castaman G; Raimondi R; Rodeghiero F
    Leuk Lymphoma; 2003 Aug; 44(8):1395-404. PubMed ID: 12952234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
    Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
    J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-Transplant CD34
    Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.
    Baker M; Wang H; Rowley SD; Cai L; Pecora AL; Skarbnik A; Vesole DH; Adler-Brecher B; Kim D; Donato ML
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2047-2055. PubMed ID: 27522040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation.
    Grubic Z; Stingl K; Cecuk Jelicic E; Zunec R; Kastelan A; Serventi Seiwerth R; Bogdanic V; Labar B; Kerhin Brkljacic V
    Clin Transplant; 2005 Oct; 19(5):586-90. PubMed ID: 16146548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer.
    Muramatsu K; Valenzuela RG; Bishop AT
    J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Progress of chimerism research after allo-bone marrow transplantation].
    Ren YL; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):168-72. PubMed ID: 12513824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative assessment of hematopoietic chimerism by quantitative real-time polymerase chain reaction of sequence polymorphism systems after hematopoietic stem cell transplantation.
    Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
    Chin Med J (Engl); 2011 Aug; 124(15):2301-8. PubMed ID: 22029079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
    Winiarski J; Mattsson J; Gustafsson A; Wester D; Borgström B; Ringdén O; Ljungman P; Dalianis T
    Pediatr Transplant; 1998 May; 2(2):150-6. PubMed ID: 10082448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
    Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
    Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application of chimerism analysis to allogeneic hematopoietic stem cell transplantation by STR-PCR].
    Sun JF; Han XP; Zhao DD; Wang FF; Jin HJ; Gao CJ; DA WM; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):337-41. PubMed ID: 17493343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A dispermic chimerism detected in a Taiwanese potential unrelated hematopoietic stem cell donor.
    Yang EK; Marsh SG; Chen PY; Chen CP; Chen SP; Lin PY
    HLA; 2017 Feb; 89(2):98-103. PubMed ID: 28102039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
    Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies.
    Kliman D; Castellano-Gonzalez G; Withers B; Street J; Tegg E; Mirochnik O; Lai J; Clancy L; Gottlieb D; Blyth E
    Biol Blood Marrow Transplant; 2018 May; 24(5):1069-1078. PubMed ID: 29305193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of conditioning regimens and stem cell sources on donor-type chimerism early after stem cell transplantation.
    Sugita J; Tanaka J; Hashimoto A; Shiratori S; Yasumoto A; Wakasa K; Kikuchi M; Shigematsu A; Miura Y; Tsutsumi Y; Kondo T; Asaka M; Imamura M
    Ann Hematol; 2008 Dec; 87(12):1003-8. PubMed ID: 18636260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of chimerism formation and tolerance induction from Fas ligand mutant bone marrow donors after nonmyeloablative conditioning.
    Nusair S; Gincberg G; Almogi-Hazan O; Breuer R; Or R; Wallach-Dayan SB
    Transpl Immunol; 2012 Dec; 27(4):184-8. PubMed ID: 22801052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-10 gene polymorphism in bone marrow transplant recipients.
    Azarpira N; Ramzi M; Aghdaie MH; Darai M; Geramizadeh B
    Exp Clin Transplant; 2008 Mar; 6(1):74-9. PubMed ID: 18405249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.